1-4 of 4
Imad Tabbara, MD
Close
Sort by
Journal Articles

A Retrospective Study to Evaluate the Incidence and Severity of Peripheral Neuropathy for Relapsed/Refractory Multiple Myeloma Patients upon Retreatment with Bortezomib

James R. Berenson, MD, Jacob D. Bitran, MD, Imad Tabbara, MD FACP, Jose Lutzky, MD, Laura V. Stampleman, MD, Sikander Ailawadhi, MD, Ronald Steis, MD, Mehdi M. Moezi, MD
Journal: Blood
Blood (2014) 124 (21): 3469.
https://doi.org/10.1182/blood.V124.21.3469.3469
Published: 2014
Journal Articles

Bendamustine + Rituximab as Treatment for Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Jeffrey Vacirca, MD, Imad Tabbara, MD, FACP, Peter Acs, MD, PhD, Grace Shumaker, MD
Journal: Blood
Blood (2010) 116 (21): 2806.
https://doi.org/10.1182/blood.V116.21.2806.2806
Published: 2010
Journal Articles

Treatment of Systemic Primary Cutaneous Anaplastic Large Cell Lymphoma with High-Dose Methotrexate and Leucovorin Rescue.

Reema Batra, MD, James Boyer, MD, Thomas O’Connor, MD, Imad Tabbara, MD
Journal: Blood
Blood (2005) 106 (11): 4756.
https://doi.org/10.1182/blood.V106.11.4756.4756
Published: 2005
Journal Articles

The Use of Anti-CD20 Chimeric Monoclonal Antibody, Rituximab in Adult Patients with Treatment Refractory Immune Thrombocytopenia.

Jack Jacoub, MD, Wassim Mchlayeh, MD, Imad Tabbara, MD, Harish P. Dave, MD, Robert Siegel, MD, Geraldine P. Schechter, MD
Journal: Blood
Blood (2004) 104 (11): 3950.
https://doi.org/10.1182/blood.V104.11.3950.3950
Published: 2004